What You Should Know:
- Deloitte Centre for Health Solutions releases its thirteenth annual report, ‘Seize the Digital Momentum: Measuring the return from pharmaceutical innovation 2022’ that explores the performance of the biopharmaceutical industry (bio Pharma) and its ability to generate returns from investment in innovative new medicines.
- Since 2021, much of the world has successfully adjusted to life where COVID-19 is more endemic as vaccines and treatments reduced the risk and
Read More
Pharma
2023’s Biggest Pharma Cybersecurity Threats to Watch
Due to the recent growth of the pharmaceutical industry, the value of highly-sensitive data stored in pharmaceutical systems and the degree of the potential damage that cyberattacks on the industry can cause, it is safe to say that pharma could be one of the most targeted industries by cybercriminals in 2023. Ransomware, phishing attacks, business applications and third-party vendors will be some of the biggest threats to this key vertical as we approach the new year.
RansomwareThe threat of
Read More
8 Executive Pharmacy Predictions/Trends to Watch in 2023
Frank Harvey, CEO at Surescripts
Community pharmacists trusted to deliver care: In 2023, pharmacists will play an integral role as part of the team managing patient care for diseases like diabetes, hypertension, or multiple comorbidities. And to support this work, I predict that we will see more activity between payers, pharmacists, the government and technology organizations to ensure that pharmacists are able to perform these important activities and be reimbursed for their work.
Greg
Read More
5 Executive Healthcare Cybersecurity Predictions to Watch in 2023
Irfan Shakeel, VP of Training and Certification Services, OPSWAT
Cyberattacks on the healthcare industry will continue to increase: The healthcare industry is most vulnerable to cyberattacks, which makes it a lucrative target for cybercriminals; attacks on the healthcare industry have grown significantly in 2022, and attacks will even go further in 2023. According to IBM, healthcare breaches cost the most at $9.23 million per incident. And, most importantly, cyberattacks not only affect human
Read More
7 Life Sciences Executive Predictions to Watch in 2023
Tracy Curley, CFO and interim CEO at iSpecimen
Focusing on the macroeconomic environment, which remains impacted by the lingering COVID-19 pandemic, there continues to be uncertainty about the strength of the global, Asia Pacific, UK and US economies. High-interest rates and a potential recession remain a concern for all market participants. At ISPC, we are closely monitoring the pace of specimen transactions. We believe that this industry can be resilient through a continued economic
Read More
Exec Hires: Former WebMD Exec Joins ODAIA as New Chief Commercial Officer
What You Should Know:
- ODAIA, the company empowering pharma’s next generation of engagement with healthcare professionals through predictive analytics announces the appointment of Dr. Eric Trépanier (Pharm.D, CFA) as its new Chief Commercial Officer.
- As Chief Commerical Officer, Trépanier will drive sales of ODAIA’s MAPTUAL Sphere and MAPTUAL Field products, which aim to expand and deepen relationships between physicians and the commercial teams and sales reps at pharma
Read More
Real-World Data Startup Crescendo Health Launches with $3.2M
What You Should Know:
- Crescendo Health, a real-world data startup that's drastically reshaping how clinical researchers get access to hard-to-reach patient data to support their clinical research today officially announced its launch with $3.4M in seed funding from Define Ventures as well as the founders and CEOs of many other well-known organizations.
- Founded by the co-founder of Datavant (merged with Ciox in a $7 billion deal), and a top product-management leader from Grand
Read More
The Patient Journey Tech Stack: 10 Pharma Predictions for 2023
The complexity of demands on Market Access teams has increased in recent years, between introducing innovative therapies targeting smaller populations and higher bars from Payers and PBMs.
Now, drug manufacturers are bucking up. According to the IQVIA Institute, the prescription abandonment rate has reached 27 percent, or $76 billion annually, in specialty drugs alone. This squandered revenue has led manufacturers to increase their focus on the complex, nuanced patient journey.
As a
Read More
When Innovation Isn’t Enough: Pharma’s Next Frontier
I met Mark Cuban once. Our conversation didn’t last very long.
It was at a medical conference a few years ago. Cuban felt like a great guy to approach with an idea for a healthcare startup. We were both investors in an automation software startup called Zoba, and I of course knew him from his role on the popular entrepreneurial reality TV series Shark Tank.
A few seconds into our conversation, Cuban paused. “Healthcare is hard,” he sighed. That was his way of politely telling me: for that
Read More
Analysis: RSNA 2022: Predictions vs Reality
Much has already been written about attendance at RSNA, but from a first-hand perspective, RSNA 2022 could be regarded as a step back toward “normal”. Amongst mostly bustling halls, vendors reported very positive feedback on the volume and quality of customer meetings, with one prominent global imaging vendor citing “We’re signing deals here at the show again – things are looking up”.
Against this positive backdrop, however, the stark challenges facing radiology in a post-COVID world were
Read More
